To test whether low expression of LINC00641 could lead to ferroptotic vulnerability for lung cancer, we first explored the Cancer Therapeutics Response Portal and found that the expression of CDH2 mRNA (LINC00641 target gene) was negatively correlated with susceptibility to ferroptosis inducers ML162, ML210 and RSL3. The gene discussed is CDH2; the disease is cancer.